You are here

Israeli drugmaker Teva says CEO has stepped down

BT_20170208_SYTEVA8_2730513.jpg
CEO Vigodman (above) would be replaced in the interim by Yitzhak Peterburg, who was chairman

Tel Aviv

ISRAEL-BASED generic drugmaker Teva Pharmaceutical Industries Ltd said on Monday that chief executive Erez Vigodman was stepping down effective immediately and would be replaced on an interim basis by Yitzhak Peterburg, who has been chairman of Teva's board of directors.

sentifi.com

Market voices on:

Powered by GET.comGetCom